Clotting Disorders

A collection of features and news articles published in ASH Clinical News related to clotting disorders.

How I Treat In Brief

How I Treat in Brief: Venous Thromboembolism in Sickle Cell Disease

Arun S. Shet, MD, from the NIH’s National Heart, Lung, and Blood Institute, and Ted Wun, MD, from UC Davis Comprehensive Cancer Center in...

FDA Expands Rivaroxaban’s Indication to Include Hospitalized Patients

The U.S. Food and Drug Administration (FDA) approved the direct oral anticoagulant rivaroxaban for the prevention of venous thromboembolism (VTE) in hospitalized, acutely ill...

Representing Hemostasis and Thrombosis: An Interview With Roy Silverstein, MD

2019 American Society of Hematology (ASH) President Roy Silverstein, MD, speaks about the goals of the ASH Working Group on Hemostasis and Thrombosis. What is...
You Make the Call

Reader Responses: How would you treat a patient with a prolonged PTT and antiphospholipid...

Here’s how readers responded to a You Make the Call question about a patient with a prolonged PTT and antiphospholipid antibodies. Disclaimer: ASH does not...
You Make the Call

How would you treat a patient with a prolonged PTT and antiphospholipid antibodies?

This month, Caroline Berube, MD, discusses treatment for a patient with a prolonged PTT and antiphospholipid antibodies. And don't forget to check out next month's...

SHARE